RCT Comparing KS Versus TS

Sponsor
Università degli Studi di Sassari (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05843981
Collaborator
Dr. Dario Melodia (Other), Dr. Milena Pisano (Other), Dr. Aurea Lumbau (Other), Prof. Silvio Mario Meloni (Other), Prof. Edoardo Baldoni (Other)
42
1
2
57.1
0.7

Study Details

Study Description

Brief Summary

To compare the clinical and radiographic outcomes of two different implant systems with different implant-abutment connection: Osstem TS III (control group) versus Osstem KS (study group).

Condition or Disease Intervention/Treatment Phase
  • Device: Implant placement
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Split-mouthSplit-mouth
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
The patients, the outcome assessors (when possible) and the statistical advisors will be blind to the used implant
Primary Purpose:
Treatment
Official Title:
The Use of an Innovative, Thickened and Lasting Implant: a Split-mouth, Multicenter Randomised Controlled Trial Comparing KS Versus TS Implants for Prosthetic Rehabilitations
Anticipated Study Start Date :
Apr 30, 2023
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Jan 31, 2028

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ks dental implant

Innovative dental implant with lasting, internal conical connection of 15° and strengthened implant walls.

Device: Implant placement
Common procedures: implant placement in subjects who have lost at least two teeth and need a prosthetic implant rehabilitation. Test procedure (experimental): use of TSIII Implant. Control procedure (contro group): use KS Implant. After osseointegration, both dental implants will receive definitive prosthesis.
Other Names:
  • Dental prosthesis delivery
  • Active Comparator: TSIII dental implant

    Standard dental implant with internal conical connection of 11°.

    Device: Implant placement
    Common procedures: implant placement in subjects who have lost at least two teeth and need a prosthetic implant rehabilitation. Test procedure (experimental): use of TSIII Implant. Control procedure (contro group): use KS Implant. After osseointegration, both dental implants will receive definitive prosthesis.
    Other Names:
  • Dental prosthesis delivery
  • Outcome Measures

    Primary Outcome Measures

    1. Implant failure [Up to 5 years]

      Defined as implant mobility and/or any infection dictating implant removal, and/or implant fracture and/or any other mechanical complication rendering the implant unusable. The stability of each individual implant will be measured by the local blinded outcome assessors manually tightening the screws with a torque of 30 Ncm at abutment connection at initial loading. At 1,3 and 5 years after loading, individual implants will be manually tested for stability. Once the single crowns will be screwed, their stability will be assessed by rocking the crown with the handles of two dental instruments.

    2. Prosthesis failure [Up to 5 years]

      Whether it will not be possible to place the prosthesis because of implant failure or a prosthesis that has to be remade for any reason.

    3. Complications [Up to 5 years]

      Technical (fracture of the framework and/or the veneering material, screw loosening, etc.) and/or biologic (pain, swelling, suppuration, peri-implantitis, etc.) complications will be considered.

    Secondary Outcome Measures

    1. Peri-implant marginal bone level changes [At 1,3 and 5 years]

      Peri-implant marginal bone level changes will be assessed on periapical radiographs took with the paralleling technique at implant placement, at initial loading, 1,3 and 5 years after loading. Ideally digital radiographs should be taken, otherwise radiographs on conventional films will be scanned into TIFF format with a 600 dpi resolution, and stored in a personal computer. Peri-implant marginal bone levels will be measured using the Scion Image (Scion Corporation, Frederick, MD, USA) software. The software will be calibrated for every single image using the known distance of the first two consecutive threads. Measurements of the mesial and distal bone crest level adjacent to each implant will be made to the nearest 0.01 mm. Reference points for the linear measurements will be: the coronal margin of the implant collar and the most coronal point of bone-to-implant contact. Bone levels will be measured.

    2. Patient satisfaction [At 1,3 and 5 years]

      Patients will answer the following questions (separately for each implant): Are you satisfied with the function of your implant-supported prostheses? Possible answers: yes absolutely, yes partly, not sure, not really, absolutely not. Are you satisfied with the aesthetic outcome of your implant-supported prostheses? Possible answers: yes absolutely, yes partly, not sure, not really, absolutely not. Would you undergo the same therapy again? Possible answers: "yes" or "no".

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Any partially edentulous patient with partial edentulism, requiring at least two dental implant-supported rehabilitations, being 18 years or older, and able to sign an informed consent. Implant sites must allow the placement of two implants of at least 4 (premolars) or 4.5 (molars) mm of diameter and 8.5 mm of length. Smokers will be included and categorized into: 1) non smokers; 2) moderate smokers (smoking up to 10 cigarettes/day); 3) heavy smokers (smoking more than 11 cigarettes/day). In case of post-extractive sites, they must have been healing for at least 3 months before being treated in the study. Implants can be adjacent.

    Exclusion Criteria:
    • General contraindications to implant surgery.

    • Patients irradiated in the head and neck area.

    • Immunosuppressed or immunocompromised patients.

    • Patients treated or under treatment with intravenous amino-bisphosphonates.

    • Patients with untreated periodontitis.

    • Patients with poor oral hygiene and motivation.

    • Previous guided bone reconstruction at the intended implant sites.

    • Uncontrolled diabetes.

    • Pregnancy or nursing.

    • Substance abuser.

    • Psychiatric problems or unrealistic expectations.

    • Lack of opposite occluding dentition in the area intended for implant placement.

    • Patients with infection and or inflammation in the area intended for implant placement.

    • Patients participating in other studies, if the present protocol cannot be properly adhered to.

    • Patients referred only for implant placement and cannot be followed ant the treating centre.

    • Patients unable to be followed for 5 years.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Marco Tallarico Sassari Italy 07100

    Sponsors and Collaborators

    • Università degli Studi di Sassari
    • Dr. Dario Melodia
    • Dr. Milena Pisano
    • Dr. Aurea Lumbau
    • Prof. Silvio Mario Meloni
    • Prof. Edoardo Baldoni

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marco Tallarico, Assistant professor, Università degli Studi di Sassari
    ClinicalTrials.gov Identifier:
    NCT05843981
    Other Study ID Numbers:
    • UNISS_PHD_Osstem_1
    First Posted:
    May 6, 2023
    Last Update Posted:
    May 6, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Marco Tallarico, Assistant professor, Università degli Studi di Sassari

    Study Results

    No Results Posted as of May 6, 2023